§ 01 Overview
Overview
Khavinson bronchial/lung-derived tripeptide. Modulates monocyte/macrophage proliferation and downregulates adhesion molecules and IL-6.
Russian-lab publications.
§ 02 Mechanism
Mechanism of action
Chonluten (EDG) is proposed to modulate inflammation in bronchial epithelium by reducing adhesion molecule expression and IL-6 production in macrophages.
- 01Anti-inflammatory in bronchial tissue models
- 02Investigated for COPD
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- 5 – 10 mg per course
- Route
- SubQ
- Frequency
- Daily for 10–20 days
§ 04 Evidence
Evidence & research
Russian-lab publications.
FDA Status
Not FDA-approved.
§ 06 News
In the news
8 articles from the last 12 months · updates hourly
EDG VS JDG - VALORANT Esports | Schedule
EDG VS JDG VALORANT Esports | Schedule
EDward Gaming vs All Gamers, CN 2026 Stage 1 (19/07/2026) - SiegeGG
EDward Gaming vs All Gamers, CN 2026 Stage 1 (19/07/2026) SiegeGG
TYLOO vs EDward Gaming, CN 2026 Stage 1 (18/07/2026) - SiegeGG
TYLOO vs EDward Gaming, CN 2026 Stage 1 (18/07/2026) SiegeGG
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier - Pulse 2.0
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier Pulse 2.0
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline - TradingView
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline TradingView
EDward Gaming vs All Gamers, CN 2026 Stage 1 (11/07/2026) - SiegeGG
EDward Gaming vs All Gamers, CN 2026 Stage 1 (11/07/2026) SiegeGG
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says - marketscreener.com
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says marketscreener.com
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says - Moomoo
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says Moomoo
§ 07 Sourcing
Sourcing & supply
Regulatory status
Authentic supply from international sources
Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product.
International · 2
Cosmic Nootropic
The most credible Russian / Khavinson source for US buyers. Sources authentic bioregulators through 'Peptides Company' (ex-NPCRIZ).
Rupharma
12+ year Russian pharmacy reseller. Reviews.io 4.84/5 (81+). Has a genuine US warehouse for common peptides.
Listings are informational, not endorsement. Verify credentials and flags against FDA and PCAB databases before purchasing. Full directory & how to verify →
§ 09 Safety
Safety & side effects
Side effects
- 01Limited data
Contraindications
None specified.
§ 10 Questions
Chonluten FAQ
- What is Chonluten?
- Khavinson bronchial/lung-derived tripeptide. Modulates monocyte/macrophage proliferation and downregulates adhesion molecules and IL-6. Chonluten (EDG) is proposed to modulate inflammation in bronchial epithelium by reducing adhesion molecule expression and IL-6 production in macrophages.
- What is Chonluten used for?
- Reported uses include anti-inflammatory in bronchial tissue models and investigated for copd. Evidence strength is rated Preclinical — see the evidence section for detail.
- How is Chonluten dosed?
- Commonly referenced dosing is 5 – 10 mg per course, typically daily for 10–20 days, administered SubQ. This is educational reference only; consult a licensed clinician before use.
- What are the side effects of Chonluten?
- Commonly reported side effects include limited data. This list is not exhaustive.
- Is Chonluten legal?
- Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product. FDA status: Not FDA-approved..
§ 11 References
Selected references
- 01
Int J Mol Sci 2022
PMC8999041